Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: Federal Circuit
Last Chapter In The “Corn Wars” Or Just The Latest?
On February 28, 2012, a three-judge panel of the Fed. Cir. ruled that the Board properly ruled that Monsanto prevailed in interference no. 105,728, involving the patent claims directed broadly to transgenic corn. (A copy of this ruling is found at … Continue reading
Bayer v. Lupin – Patenting The Label Redux
In my post of January 13, 2011, I discussed AstraZeneca LP v. Apotex, a Fed. Cir. decision in which AZ argued successfully that the proposed Apotex labeling for an anti-asthma drug would induce infringement if the generic were marketed with … Continue reading
Supreme Court Declines To Review “New And Improved” Written Description Requirement
On Tuesday, the Supreme Court denied Centocor’s (now “Janssen”) petition for cert. and so let stand a ruling that Centocor’s patents on humanized monoclonal antibodies (covering Abbott’s Humira) are invalid for failure to meet the written description requirement (WDR) of … Continue reading
Top 2011 IP Stories on Patents4Life
I spent a day or two looking back over the breaking IP news that resulted in posts on Patents4Life. I wrote most of them, but want to take a pause to thank regular contributors Paul Cole, Ron Schutz and Stefan … Continue reading
Posted in Miscellaneous
Tagged AIA, America Invents Act, AMP, ANDA, Bayh-Dole Act, biotechnology, biotechnology law, biotechnology news, caraco, court of appeals, Dr. Stefan Danner, European patent, Federal Circuit, intellectual property, ip, microsoft v i4i, Myriad, Patent Law, patents, Paul Cole, Pharmaceutical law, Prometheus v. Mayo, saint-gobain, Schutz, sherley, Stanford v Roche, Supreme Court, Therasense, USPTO, Warren Woessner, WDR
Leave a comment